APA (7th ed.) Citation

Boku, S., Ikoma, T., Yasuda, T., Shibata, N., Sakagami, T., Suzuki, K., . . . Kanai, M. Relationship between the effectiveness of pembrolizumab monotherapy and ABO blood type in recurrent and metastatic squamous cell carcinoma of the head and neck. Springer.

Chicago Style (17th ed.) Citation

Boku, Shogen, Tatsuki Ikoma, Tomoyo Yasuda, Nobuhiro Shibata, Tomofumi Sakagami, Kensuke Suzuki, Takuo Fujisawa, Hiroshi Iwai, and Masashi Kanai. Relationship Between the Effectiveness of Pembrolizumab Monotherapy and ABO Blood Type in Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck. Springer.

MLA (9th ed.) Citation

Boku, Shogen, et al. Relationship Between the Effectiveness of Pembrolizumab Monotherapy and ABO Blood Type in Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck. Springer.